Anti-EZH1 antibody (ab64850)
Key features and details
- Rabbit polyclonal to EZH1
- Suitable for: WB, IHC-P
- Reacts with: Mouse, Human, African green monkey
- Isotype: IgG
Overview
-
Product name
Anti-EZH1 antibody
See all EZH1 primary antibodies -
Description
Rabbit polyclonal to EZH1 -
Host species
Rabbit -
Specificity
This antibody detects endogenous levels of total EZH1 protein. -
Tested Applications & Species
See all applications and species dataApplication Species IHC-P HumanWB Human
-
Immunogen
Synthetic peptide corresponding to Human EZH1 aa 171-220 (internal sequence).
Database link: Q92800 -
Positive control
- WB: Extract from LOVO, HT-29, A549, NIH-3T3, RAW264.7, COS-7 cells. IHC-P: Human brain tissue.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Without Mg2+ and Ca2+ -
Concentration information loading... -
Purity
Immunogen affinity purified -
Purification notes
The antibody was affinity purified from rabbit antiserum by affinity chromatography using epitope specific immunogen. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Western blot - Anti-EZH1 antibody (ab64850)All lanes : Anti-EZH1 antibody (ab64850) at 1/500 dilution
Lane 1 : Extracts from HT-29 cells
Lane 2 : Extract from LOVO
cells
Lane 3 : Extracts from A549 cells
Lane 4 : Extracts from NIH-3T3 cells
Lane 5 : Extracts from RAW264.7 cells
Lane 6 : Extracts from COS-7 cells
Lane 7 : Extracts from COS-7 cells with blocking peptide at 5 µg
Lysates/proteins at 5 µg per lane.
Predicted band size: 85 kDa
Observed band size: 85 kDa
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EZH1 antibody (ab64850)Ab64850 (1/50 dilution) staining EZH1 in paraffin embedded human brain tissue by immunohistochemistry.
The left panel is in the absence of blocking peptide, whereas the right panel is in the presence of blocking peptide.
